Roelof W Feenstra

Title: Roelof W Feenstra: Innovator in Pharmacological Compounds

Introduction

Roelof W Feenstra is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmacology, particularly through his innovative work on phenylpiperazine derivatives and piperazine compounds. With a total of 13 patents to his name, Feenstra's inventions have the potential to impact the development of new medications.

Latest Patents

One of his latest patents involves a group of novel phenylpiperazine derivatives that exhibit a dual mode of action. These compounds function as serotonin reuptake inhibitors while also acting as partial agonists on dopamine-D receptors. The invention outlines the use of these compounds in the manufacture of medicaments that provide beneficial effects. The compounds are described by a general formula, which includes tautomers, stereoisomers, and N-oxides, as well as pharmacologically acceptable salts, hydrates, and solvates. Additionally, Feenstra has developed a group of new piperazine and piperidine compounds that possess advantageous pharmacological properties.

Career Highlights

Throughout his career, Roelof W Feenstra has worked with prominent companies in the pharmaceutical industry. Notable among these are Solvay Pharmaceuticals and Duphar International Research. His work in these organizations has allowed him to advance his research and contribute to the development of innovative pharmacological solutions.

Collaborations

Feenstra has collaborated with esteemed colleagues, including Cornelis G Kruse and Stephen K Long. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Roelof W Feenstra's contributions to the field of pharmacology through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new therapeutic options that can benefit patients worldwide.